STRO icon

Sutro Biopharma
STRO

Overview Fund Activity

64 hedge funds and large institutions have $128M invested in Sutro Biopharma in 2019 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 26 increasing their positions, 9 reducing their positions, and 6 closing their positions.

Holders
64
Holders Change
+5
Holders Change %
+8.47%
% of All Funds
1.26%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
11
Increased
26
Reduced
9
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
EAM
1
Eventide Asset Management
Massachusetts
$13.7M
2
O
2
OrbiMed
New York
$1.15M
3
GPCM
3
Granite Point Capital Management
Massachusetts
$1.1M
4
Jacobs Levy Equity Management
4
Jacobs Levy Equity Management
New Jersey
$719K
5
ECM
5
Endurant Capital Management
California
$359K

Top Sellers

1
SFM
1
Sphera Funds Management
Israel
$0
2
Jennison Associates
2
Jennison Associates
New York
$0
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$1.75M
4
HSBC Holdings
4
HSBC Holdings
United Kingdom
$0
5
Creative Planning
5
Creative Planning
Kansas
$234K
Name Market Value Shares Shares
Change 		Shares
Change %
SHI
1
SV Health Investors
Massachusetts
$20.1M 1,824,542 – –
Citadel Advisors
2
Citadel Advisors
Florida
$19M 1,728,976 -828 -0%
EAM
3
Eventide Asset Management
Massachusetts
$13.7M 1,244,895 +719,895 +137%
SB
4
Samsara BioCapital
California
$12.4M 1,125,579 – –
VM
5
VV Manager
Massachusetts
$11M 995,579 – –
BlackRock
6
BlackRock
New York
$7.12M 647,107 +3,088 +0.5%
TCM
7
Tekla Capital Management
Massachusetts
$7.05M 641,268 – –
CCM
8
Camber Capital Management
Massachusetts
$6.6M 600,000 – –
BI
9
BVF Inc
California
$3.8M 345,196 +1,000 +0.3%
Vanguard Group
10
Vanguard Group
Pennsylvania
$3.75M 340,587 +17,288 +5%
DCM
11
Driehaus Capital Management
Illinois
$3.09M 280,934 +1,357 +0.5%
State Street
12
State Street
Massachusetts
$1.86M 169,466 +13,628 +9%
Fidelity Investments
13
Fidelity Investments
Massachusetts
$1.75M 158,700 -63,900 -29%
IBT
14
International Biotechnology Trust
United Kingdom
$1.53M 139,331 – –
Northern Trust
15
Northern Trust
Illinois
$1.34M 122,180 +756 +0.6%
O
16
OrbiMed
New York
$1.15M 104,800 +104,800 New
JPMorgan Chase & Co
17
JPMorgan Chase & Co
New York
$1.14M 103,418 +4,876 +5%
GPCM
18
Granite Point Capital Management
Massachusetts
$1.1M 100,000 +100,000 New
Geode Capital Management
19
Geode Capital Management
Massachusetts
$1.06M 96,216 +3,841 +4%
PCM
20
Pentwater Capital Management
Florida
$879K 79,892 -9,189 -10%
Jacobs Levy Equity Management
21
Jacobs Levy Equity Management
New Jersey
$719K 65,334 +34,548 +112%
OAM
22
Oxford Asset Management
United Kingdom
$660K 60,008 +14,348 +31%
BCM
23
Bridgeway Capital Management
Texas
$629K 57,200 +8,400 +17%
Acadian Asset Management
24
Acadian Asset Management
Massachusetts
$501K 45,447 +14,736 +48%
DCM
25
DAFNA Capital Management
California
$440K 40,000 – –
1
2 3